PharmaCielo Begins CBD Exports To Spanish Pharma Processor

Canadian – Colombian cannabis producer PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), this week announced that it has made an initial shipment of CBD full spectrum oil containing THC to Extractions Solutions SL, a Spanish natural pharmaceutical company that specializes in the post-processing and refinement of cannabis derivatives. Extractions Solutions intends to use PharmaCielo’s product to develop CBD derivatives to be produced in Spain and distributed across Europe.

“Extractions Solutions is an innovative, rapidly growing cannabinoid post-processor, refiner and manufacturer, with an established customer base across the European market. With a commitment to providing high quality products and custom solutions, as well as seed to solution traceability, PharmaCielo was a logical choice as we continue to build-out our product portfolio. PharmaCielo has the quality, consistency, sophistication, and scale that we require of our API partners, and we look forward to continuing to advance the relationship as we seek to serve our customers across the EU, and globally,” said Dirk Eduard M. de Maeyer, Executive Director of Extractions Solutions

Bill Petron, CEO of PharmaCielo added: “We are pleased to announce our entrance into a new market, with the initial shipment of PharmaCielo API1 to Extractions Solutions, in support of their product development efforts. This serves to further expand our distribution network throughout Europe, building on our recent announcements that we will be bringing PharmaCielo products to the German and Polish medical cannabis markets. Our sales team has already made substantial progress in the first five months of 2022, and we expect to continue this trend through the rest of the year as we drive toward increased revenues and sustained profitability.”